When and where is JIHE 2026 held?

JIHE 2026 will be held on November 13-14, 2026 at House of OMOTESANDO (5-34-8 Jingumae, Shibuya-ku, Tokyo).

Is there an admission fee?

General admission is free with pre-registration. Some programs, such as the networking party, may require additional fees.

How can I become an exhibitor?

You can apply to exhibit through the contact form on our official website. We offer various booth and sponsorship packages to suit your needs.

How can I apply to speak at the conference?

If you'd like to speak at CannaCon, please submit your application through our contact form and select 'Speaker.' We welcome presentations from international experts in the hemp and cannabis industry.

What kind of programs does JIHE offer?

JIHE features exhibitions (CBD Journey & HEMP Journey), conferences (CannaCon), networking events, and hands-on workshops — offering a comprehensive hemp industry experience.

Can international visitors attend?

Yes, JIHE is an international expo. We welcome visitors, exhibitors, and speakers from around the world. Sessions by international speakers cross the language barrier with AI interpretation.

Does JIHE have a track record of past events?

Yes, JIHE evolved from the integration of CBD Journey and CannaCon events. You can view past attendance figures and exhibitor details on our Past Event Reports page.

JIHE 2026 / PROGRAM

Learn and explore. Enjoy both days.

Learn in the sessions, explore the exhibitions and connect with the community. Make the most of both days in the world of CBD and hemp.

11.13 — 11.14

2026 · House of OMOTESANDO

Speaker and participating company information will be added progressively. As of 2 October 2026.

2F White Hall

CannaCon sessions

Session times are provisional and subject to change. All times are Japan Standard Time (JST).

Session language

Fri 13 Nov

BUSINESS DAY

Meet the industry. Explore what comes next.

10:30　Doors open

11:00–11:10
Business Day opening remarks
11:10–12:4090 min
Japanese & English, AI subtitlesProvisional
What Japan's hemp industry needs to grow: cultivation, seeds, breeding and regulation
Hemp cultivation under Japan's new regulatory framework began in 2025, but entering the industry still involves many hurdles. What stands in the way, and what is needed, for more growers to join and for the industry to develop? Drawing on the situation in Mongolia, Austria and Singapore, this session explores the keys to growing the industry.
12:40–12:50
Break
12:50–13:5060 min
JapaneseProvisional
Will cannabis-derived medicines ever be available in Japan?
Overseas, medicines made with cannabis-derived ingredients, such as Epidiolex for epilepsy and Sativex for multiple sclerosis, are already used in clinical practice. In Japan, however, challenges remain on the road to practical use, from legal regulation to the development and approval systems. This session shares the status of bringing Epidiolex to Japan, the current state of specified clinical research and AMED projects, and moves to introduce products developed overseas, and discusses what is needed to deliver cannabis-derived medicines to patients in Japan.
13:50–14:00
Break
14:00–15:0060 min
Japanese & English, AI subtitlesProvisional
Medical cannabis and cancer care
In cancer care, how we address pain, nausea, anxiety and delirium — and how we support the quality of life of patients and their families — matters as much as the treatment itself. Cannabinoids have been applied and studied in palliative and supportive care overseas, and a change in the law has now opened the way for cannabis-derived medicines in Japan. This session brings together long experience in palliative care and cannabinoid therapy in the United States and the perspective of psycho-oncology in Japan, where the focus is on delirium, cognitive function and psychological symptoms in cancer patients, to discuss where medical cannabis and cancer care stand today and what can be considered in Japanese clinical practice.
15:00–15:10
Break
15:10–16:1060 min
JapaneseProvisional
CBN today and the inconvenient truth
CBN has been regulated as a designated substance since June 2026. Yet a path remains for people with a recognised therapeutic need to keep using it as a 'legitimate use'. Through the design of the system and how eligibility is assessed in practice, the challenges faced by doctors who issue medical certificates, and the voices of patients themselves, this session examines from several angles where CBN regulation stands today and the 'inconvenient truths' that have surfaced in its shadow.
16:10–16:20
Break
16:20–17:5090 min
Japanese & English, AI subtitlesProvisional
Quality control and traceability: connecting every step from cultivation to the consumer
As the number of places where medical cannabis and hemp-derived CBD products are legal grows, and rules for regulation and oversight take shape, there is still no shortage of operators who try to get around them. Sound quality control and traceability are challenges that producers and distributors cannot avoid if they are to deliver compliant, high-quality products to consumers. Centred on the quality management system developed by TrueImports, this session discusses the quality control needed to build a healthy market.
17:50–18:00
Day 1 closing and reception information
18:00–18:30
Room changeover for the networking reception

18:30〜 approx.　Networking reception

2F / RF · Advance registration required, paid

Book the reception on Peatix

22:00　Doors close

Sat 14 Nov

COMMUNITY DAY

Discover hemp through everyday life and healthcare.

10:30　Doors open

11:00–12:3090 min
EnglishProvisional
Latest trends in the CBD and cannabis industry overseas and their impact on the Japanese market
Comprehensive regulation of hemp-derived CBD products has stalled in many countries. In the United States, the THC content of hemp-derived CBD products will be restricted from December, and many products now on the market are expected to become unsellable. This session examines the pros and cons of this THC regulation and its impact on the CBD market, particularly for people who use CBD for medical purposes.
12:30–12:40
Break
12:40–13:5070 min
JapaneseProvisional
Go-to-market strategies for Japan's hemp industry: what should we make to reach consumers?
For Japan's hemp industry to grow sustainably, the question is not only what we can make, but what we should make to reach consumers. This session brings together practitioners exploring hemp across food, traditional industries, textiles and apparel, and material development. Through their work, we discuss the ideas, challenges and possibilities needed to turn Japanese hemp into products that sell and products that people choose.
13:50–14:00
Break
1. 14:00〜Times to be confirmed
  Japanese & English, AI subtitlesProvisional
  Cutting-edge initiatives and case studies in CBD and hemp
  Individual presentations are planned. Presentation order, individual speaking times and the moderator are being arranged.
2. Times to be confirmed
  EnglishProvisional
  The Future of the U.S. Hemp Industry: Government Support, Global Trade & Opportunities for Japan–U.S. Collaboration
  A delegation from the National Industrial Hemp Council of America (NIHC) and fellow speakers discuss the current direction of the U.S. hemp industry, government support for the sector and international trade. The panel also explores opportunities for collaboration between Japan and the United States.
16:45–16:55
Break
16:55–17:5560 min
JapaneseProvisional
Cannabis in integrative medicine: cannabis as a medicinal herb and the potential of terpenes
Cannabis has been used as a medicinal herb around the world since ancient times, and it contains many plant compounds besides cannabinoids. Terpenes have drawn attention in the cannabis world only relatively recently, yet in herbal medicine they have long played an important role. When we see cannabis as a medicinal herb, what can we expect from terpenes? This session explores their potential.
17:55–18:00
Closing remarks

18:00　Doors close

More to discover between sessions.

All sessions take place on 2F. Explore the exhibitions and meet people on the other floors between sessions.

B1F

Sky Hall

Main exhibition and stage

Lounge

Reception, business meetings and drinks bar

White Hall

CannaCon conference and bar counter

Rooftop Terrace

Networking and booths

Venue map ↗Explore participating companies ↗Meet the speakers ↗

Thu 12 Nov · Pre-event programme for participants and partners

All daySet-up and move-inFor participating companies
13:00–17:30 approx.AIHF International ConsultationBy invitation or application
18:30〜 approx.Reception for participants and partners

Add to Google Calendar iCal / Outlook (.ics)